Skip to main content
Loading

Eupraxia Pharmaceuticals

February 10, 2025
Gastrointestinal
Eupraxia Pharmaceuticals
Eupraxia Pharmaceuticals is a biotechnology company focused on precision delivery of drugs into disease tissues using its proprietary Diffusphere technology. With its lead program in Eosinophilic Esophagitis and a Phase 3 ready program in Osteoarthritis it is advanced in building its product pipeline
Speakers
James Helliwell, CEO - Eupraxia Pharmaceuticals
View all 2025 Program
Testimonials

Double Helix


 

Supporting Bank Sponsor


 

Premier Sponsors

Conference Sponsors


 

Sign up for updates

Stay up-to-date on the BIO CEO and Investor Conference via email.

SIGN UP